» Articles » PMID: 36297063

Celiac Disease and Gallbladder: Pathophysiological Aspects and Clinical Issues

Overview
Journal Nutrients
Date 2022 Oct 27
PMID 36297063
Authors
Affiliations
Soon will be listed here.
Abstract

: Celiac Disease (CD) is an immune-mediated disorder which primarily affects the small intestine; however, extra-intestinal organs are often affected by the pathological process, too. As regards the digestive system, liver alterations in CD patients have been widely described, which can also extend to the biliary tract. Notably, gallbladder function can be altered in CD patients. In this review, we specifically analyze and summarize the main pathophysiological aspects and clinical evidence of gallbladder dysfunction in CD patients, in order to discuss the potential medical complications and clinical research gaps. In addition to some perturbations of bile composition, CD patients can develop gallbladder dysmotility, which mainly expresses with an impaired emptying during the digestive phase. The main pathophysiological determinant is a perturbation of cholecystokinin secretion by the specific duodenal enteroendocrine cells in response to the appropriate nutrient stimulation in CD patients. This situation appears to be reversible with a gluten-free diet in most cases. Despite this gallbladder impairment, CD patients do not seem to be more predisposed to gallbladder complications, such as calculous and acalculous cholecystitis. However, very few clinical studies have actively investigated these clinical aspects, which may not be completely evidenced so far; alternatively, the substantial improvements in the last two decades regarding CD diagnosis, which have reduced the diagnostic delay (and related dietary treatment), may have lessened the potential clinical consequences of CD-related gallbladder dysfunction. Specific clinical studies focused on these aspects are needed for a better understanding of the clinical implications of gallbladder alterations in CD patients.

Citing Articles

Proteomic analysis of plasma and duodenal tissue in celiac disease patients reveals potential noninvasive diagnostic biomarkers.

Li N, Maimaitireyimu A, Shi T, Feng Y, Liu W, Xue S Sci Rep. 2024; 14(1):29872.

PMID: 39622892 PMC: 11612483. DOI: 10.1038/s41598-024-80391-5.

References
1.
Thimister P, Hopman W, ROSENBUSCH G, Jansen J . Plasma cholecystokinin and gallbladder responses to increasing doses of bombesin in celiac disease. Dig Dis Sci. 1998; 43(3):668-72. DOI: 10.1023/a:1018844031460. View

2.
Harvey R, DAVIES E, Read A . Abnormalities of serum cholecystokinin and gallbladder emptying in celiac disease. N Engl J Med. 1975; 292(18):961-3. DOI: 10.1056/NEJM197505012921807. View

3.
Maton P, Selden A, Fitzpatrick M, Chadwick V . Defective gallbladder emptying and cholecystokinin release in celiac disease. Reversal by gluten-free diet. Gastroenterology. 1985; 88(2):391-6. DOI: 10.1016/0016-5085(85)90497-4. View

4.
Poddighe D, Rebuffi C, De Silvestri A, Capittini C . Carrier frequency of HLA-DQB1*02 allele in patients affected with celiac disease: A systematic review assessing the potential rationale of a targeted allelic genotyping as a first-line screening. World J Gastroenterol. 2020; 26(12):1365-1381. PMC: 7109277. DOI: 10.3748/wjg.v26.i12.1365. View

5.
Rehfeld J . Clinical endocrinology and metabolism. Cholecystokinin. Best Pract Res Clin Endocrinol Metab. 2004; 18(4):569-86. DOI: 10.1016/j.beem.2004.07.002. View